Skip to content

DMT alters cortical travelling waves.

Andrea Alamia, Christopher Timmermann, David Nutt, Rufin Vanrullen, Robin Carhart-Harris

Elife October 12, 2020 DOI: 10.7554/elife.59784 (opens in new tab)

The journal has published a correction to this paper. Read the correction (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Placebo-controlled crossover trial Peer reviewed
Population Participants receiving DMT and placebo (saline) with eyes closed
Intervention N
Topics DMT
Keywords Psychedelics: DMT Psychedelic experiences Electrical activity Cortical travelling waves Consciousness: conscious experience Perception Brain's dynamic nature
Citations 86
Key findings DMT reduced top-down alpha rhythms and increased bottom-up forward cortical travelling waves, supporting a model where psychedelics reduce the precision-weighting of priors.

Abstract

Psychedelic drugs are potent modulators of conscious states and therefore powerful tools for investigating their neurobiology. N,N, Dimethyltryptamine (DMT) can rapidly induce an extremely immersive state of consciousness characterized by vivid and elaborate visual imagery. Here, we investigated the electrophysiological correlates of the DMT-induced altered state from a pool of participants receiving DMT and (separately) placebo (saline) while instructed to keep their eyes closed. Consistent with our hypotheses, results revealed a spatio-temporal pattern of cortical activation (i.e. travelling waves) similar to that elicited by visual stimulation. Moreover, the typical top-down alpha-band rhythms of closed-eyes rest were significantly decreased, while the bottom-up forward wave was significantly increased. These results support a recent model proposing that psychedelics reduce the 'precision-weighting of priors', thus altering the balance of top-down versus bottom-up information passing. The robust hypothesis-confirming nature of these findings imply the discovery of an important mechanistic principle underpinning psychedelic-induced altered states.

Comparable studies

Other randomized controlled trials on DMT, most cited first.

Study Year Design Participants
Dose-Response Study of N,N-Dimethyltryptamine in Humans Experienced hallucinogen users 1994 Double-blind, saline placebo-controlled, randomized study n = 12
DMT Models the Near-Death Experience Healthy participants 2018 Within-subjects placebo-controlled study n = 13
Human brain effects of DMT assessed via EEG-fMRI. Healthy volunteers 2023 Within-subjects, placebo-controlled design n = 20
Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers Healthy volunteers 2005 Double-blind crossover study n = 9
Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans Experienced hallucinogen users 1996 Randomized controlled trial n = 13

Citations in the library

Explore topics